CYCLO(-GLY-GLN) | CAS:52662-00-7

We serve CYCLO(-GLY-GLN) CAS:52662-00-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
CYCLO(-GLY-GLN)

Synonyms:
CYCLO(GLY-L-GLN)
3-((S)-3,6-Dioxo-piperazin-2-yl)-propionsaeure-amid
cyclo(Gly-Gln)
cyclo(glycyl-glutamine)
(S)-3-(3,6-Dioxopiperazin-2-yl)propanamide
Cyclo(glycyl-L-glutaminyl)
(S)-3,6-Dioxo-2-piperazinepropanamide
3-[(2S)-3,6-DIOXOPIPERAZIN-2-YL]PROPANAMIDE
2-Piperazinepropanamide,3,6-dioxo-,(S)-(9CI)
3-((S)-3,6-dioxo-piperazin-2-yl)-propionic acid amide
(2S)-HEXAHYDRO-3,6-DIOXO-PYRAZINEPROPANAMIDE
 
Molecular Formula:  C7H11N3O3
Molecular weight:185.08000

Refractive index: 1.498
 
Uses: Cyclo(Gly-Gln) is a cyclic dipeptide.
Storage conditions: -15ºC

Items of Analysis Standard of Analysis Test Results
Appearance White powder Conform
Purity(HPLC) ≥98% 99.47%
Inorganic salt May not be detected Conform
Loss on drying ≤0.5% 0.01%
Conclusion Conforms to Factory Standard
 




Contact us for information like CYCLO(-GLY-GLN) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S)-HEXAHYDRO-3,6-DIOXO-PYRAZINEPROPANAMIDE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-((S)-3,6-dioxo-piperazin-2-yl)-propionic acid amide Use and application,3-((S)-3,6-Dioxo-piperazin-2-yl)-propionsaeure-amid technical grade,usp/ep/jp grade.


Related News: High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies.1L-1,2,3-O-benzyl-6-deoxy-6-(benzyloxymethyl)-chiro-inositol manufacturer Slow business: Due to fear — and travel warnings — fewer people want to travel to China. methyl 4-chloro-6-fluoro-2-isobutyl-7-(3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl)benzofuran-3-carboxylate supplier China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.rac-Des(4-cyclohexyl-L-proline) Fosinopril Acetic Acid vendor Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.